|
1.
|
Stolbach LL. Does "fighting spirit" improve medical outcomes of cancer patients? Adv Mind Body Med. 2003; 19(2):17-8.
|
|
|
|
|
2.
|
de la Torre M, Stolbach L, Fulop JA, Grotto D, Sagar SM, Hidenbrand G, Block KI. Integrative tumor board: recently diagnosed lung cancer. Integr Cancer Ther. 2002 Sep; 1(3):246-65.
|
|
|
|
|
3.
|
Tandar A, Abraham G, Gurka J, Wendel M, Stolbach L. Recurrent peritoneal mesothelioma with long-delayed recurrence. J Clin Gastroenterol. 2001 Sep; 33(3):247-50.
|
|
|
|
|
4.
|
Schnoll R, Harlow LL, Brandt U, Stolbach LL. Using two factor structures of the Mental Adjustment to Cancer (MAC) scale for assessing adaptation to breast cancer. Psychooncology. 1998 Sep-Oct; 7(5):424-35.
|
|
|
|
|
5.
|
Schnoll RA, Harlow LL, Stolbach LL, Brandt U. A structural model of the relationships among stage of disease, age, coping, and psychological adjustment in women with breast cancer. Psychooncology. 1998 Mar-Apr; 7(2):69-77.
|
|
|
|
|
6.
|
Schwartz CE, Daltroy LH, Brandt U, Friedman R, Stolbach L. A psychometric analysis of the Mental Adjustment to Cancer scale. Psychol Med. 1992 Feb; 22(1):203-10.
|
|
|
|
|
7.
|
O'Connor AM, Boyd NF, Warde P, Stolbach L, Till JE. Eliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation technique and treatment experience on preferences. J Chronic Dis. 1987; 40(8):811-8.
|
|
|
|
|
8.
|
Bonomi PD, Pazdur R, Stolbach L, Mason B, Ettinger D. Phase II trial of mitomycin, vindesine, and hexamethylmelamine in metastatic non-small cell bronchogenic carcinoma. Cancer Treat Rep. 1986 Dec; 70(12):1447-8.
|
|
|
|
|
9.
|
Vogl SE, Komisar A, Kaplan BH, Engstrom PF, Kasule OH, Stolbach L, Lerner H, Muggia F. Sequential methotrexate and 5-fluorouracil with bleomycin and cisplatin in the chemotherapy of advanced squamous cancer of the head and neck. Cancer. 1986 Feb 15; 57(4):706-10.
|
|
|
|
|
10.
|
Bonomi P, O'Reilly W, Vogl SE, Ruckdeschel JC, Stolbach L, Bunting N, Creech RH. Intensive induction treatment of small cell bronchogenic carcinoma with cyclophosphamide, methotrexate, and etoposide. Cancer Treat Rep. 1985 Sep; 69(9):1007-9.
|
|
|
|
|
11.
|
Ruckdeschel JC, Day R, Weissman CH, Stolbach LL, Creech RH. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: cyclophosphamide, doxorubicin, and etoposide versus mitomycin and vinblastine (EST 2575, generation IV). Cancer Treat Rep. 1984 Nov; 68(11):1325-9.
|
|
|
|
|
12.
|
Stewart DJ, Maroun JA, Hirte W, Perrault D, Stolbach L, Cripps C, Lefebvre B. A randomized comparison of cyclophosphamide-mitoxantrone-5-fluorouracil v cyclophosphamide-doxorubicin-5-fluorouracil in advanced breast cancer: preliminary observations. Semin Oncol. 1984 Sep; 11(3 Suppl 1):23-7.
|
|
|
|
|
13.
|
Begg CB, Zelen M, Carbone PP, McFadden ET, Brodovsky H, Engstrom P, Hatfield A, Ingle J, Schwartz B, Stolbach L. Cooperative groups and community hospitals. Measurement of impact in the community hospitals. Cancer. 1983 Nov 1; 52(9):1760-7.
|
|
|
|
|
14.
|
Hoeltgen TM, MacIntyre JM, Perlia CP, Lagakos SW, Stolbach LL, Bennett JM. Adriamycin and Cytoxan in the treatment of inoperable lung cancer. Cancer. 1983 Jun 1; 51(11):2005-12.
|
|
|
|
|
15.
|
Stewart DJ, Russell N, Atack EA, Quarrington A, Stolbach L. Cyclophosphamide, doxorubicin, vincristine, and dexamethasone in primary lymphoma of the brain: a case report. Cancer Treat Rep. 1983 Mar; 67(3):287-91.
|
|
|
|
|
16.
|
Stolbach L, Begg C, Bennett JM, Silverstein M, Falkson G, Harris DT, Glick J. Evaluation of bone marrow toxic reaction in patients treated with allopurinol. JAMA. 1982 Jan 15; 247(3):334-6.
|
|
|
|
|
17.
|
Cantarow WD, Stolbach LL, Bhattacharya M, Chatterjee SK, Barlow JJ. The value of tumor markers in cancer of the ovary. Int J Radiat Oncol Biol Phys. 1981 Aug; 7(8):1095-8.
|
|
|
|
|
18.
|
Stolbach LL, Begg CB, Hall T, Horton J. Treatment of renal carcinoma: a phase III randomized trial of oral medroxyprogesterone (Provera), hydroxyurea, and nafoxidine. Cancer Treat Rep. 1981 Jul-Aug; 65(7-8):689-92.
|
|
|
|
|
19.
|
Rosenbaum C, Marsland TA, Stolbach LL, Raam S, Cohen JL. Estrogen receptor status and response to chemotherapy in advanced breast cancer: the Tufts-Shattuck-Pondville experience. Cancer. 1980 Dec 15; 46(12 Suppl):2919-21.
|
|
|
|
|
20.
|
Lin CW, Inglis NR, Rule AH, Turksoy RN, Chapman CM, Kirley SD, Stolbach LL. Histaminase and other tumor markers in malignant effusion fluids. Cancer Res. 1979 Dec; 39(12):4894-9.
|
|
|
|
|
21.
|
Lenhard RE, Ezdinli EZ, Costello W, Bennett JM, Horton J, Amorisi EL, Stolbach L, Wolter J. Treatment of histiocytic and mixed lymphomas: a comparison of two, three and four drug chemotherapy. Cancer. 1978 Jul; 42(1):41-52.
|
|
|
|
|
22.
|
Meyer JE, Stolbach L. Pretreatment radiographic evaluation of patients with malignant melanoma. Cancer. 1978 Jul; 42(1):125-6.
|
|
|
|
|
23.
|
Malagelada JR, Stolbach LL, Linscheer WG. Influence of carbon chain length of dietary fat on intestinal alkaline phosphatase in chylous ascites. Am J Dig Dis. 1977 Jul; 22(7):629-32.
|
|
|
|
|
24.
|
Linscheer WG, Malagelada JR, Stolbach LL, Fishman WH. The effect of fatty acid perfusion on intestinal alkaline phosphatase. I. Studies on man. Am J Dig Dis. 1977 Jun; 22(6):509-15.
|
|
|
|
|
25.
|
Ezdinli E, Pocock S, Berard CW, Aungst CW, Silverstein M, Horton J, Bennett J, Bakemeier R, Stolbach L, Perlia C, Brunk SF, Lenhard RE, Klaassen DJ, Richter P, Carbone P. Comparison of intensive versus moderate chemotherapy of lymphocytic lymphomas: a progress report. Cancer. 1976 Sep; 38(3):1060-8.
|
|
|
|
|
26.
|
Lenhard RE, Prentice RL, Owens AH, Bakemeier R, Horton JH, Shnider BI, Stolbach L, Berard CW, Carbone PP. Combination chemotherapy of the malignant lymphomas: a controlled clinical trial. Cancer. 1976 Sep; 38(3):1052-9.
|
|
|
|
|
27.
|
Edmonson JH, Lagakos SW, Selawry OS, Perlia CP, Bennett JM, Muggia FM, Wampler G, Brodovsky HS, Horton J, Colsky J, Mansour EG, Creech R, Stolbach L, Greenspan EM, Levitt M, Israel L, Ezdinli EZ, Carbone PP. Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung. Cancer Treat Rep. 1976 Jul; 60(7):925-32.
|
|
|
|
|
28.
|
Knight EW, Lagakos S, Stolbach L, Colsky J, Horton J, Israel L, Bennett J, Perlia C, Regelson W, Carbone PP. Adriamycin in the treatment of far-advanced lung cancer. Cancer Treat Rep. 1976 Jul; 60(7):939-41.
|
|
|
|
|
29.
|
Edmonson JH, Lagakos S, Stolbach L, Perlia CP, Bennett JM, Mansour EG, Horton J, Regelson W, Cummings FJ, Israel L, Brodsky I, Shnider BI, Creech R, Carbone PP. Mechlorethamine (NSC-762) plus CCNU (NSC-79037) in the treatment of inoperable squamous and large cell carcinoma of the lung. Cancer Treat Rep. 1976 May; 60(5):625-7.
|
|
|
|
|
30.
|
Miller MS, Costanza ME, Li FP, Stolbach L, Stone R, Nathanson L. Familial colon cancer. Cancer. 1976 Feb; 37(2):946-8.
|
|
|
|
|
31.
|
Dorsett BH, Ioachim HL, Stolbach L, Walker J, Barber HR. Isolation of tumor-specific antibodies from effusions of ovarian carcinomas. Int J Cancer. 1975 Nov 15; 16(5):779-86.
|
|
|
|
|
32.
|
Miller SP, Brenner S, Horton J, Stolbach L, Shnider BI, Pocock S. Comparative evaluation of combined radiation-chlorambucil treatment of ovarian carcinomatosis. Cancer. 1975 Nov; 36(5):1625-30.
|
|
|
|
|
33.
|
Lin CW, Orcutt ML, Stolbach LL. Elevation of histaminase and its concurrence with Regan isoenzyme in ovarian cancer. Cancer Res. 1975 Oct; 35(10):2762-5.
|
|
|
|
|
34.
|
Fishman WH, Inglis NR, Vaitukaitis J, Stolbach LL. Regan isoenzyme and human chorionic gonadotropin in ovarian cancer. Natl Cancer Inst Monogr. 1975 Oct; 42:63-73.
|
|
|
|
|
35.
|
Fishman WH, Raam S, Stolbach LL. Markers for ovarian cancer: regan isoenzyme and other glycoproteins. Semin Oncol. 1975 Sep; 2(3):211-6.
|
|
|
|
|
36.
|
Heppner G, Henry E, Stolbach L, Cummings F, McDonough E, Calabresi P. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells. Cancer Res. 1975 Aug; 35(8):1931-7.
|
|
|
|
|
37.
|
Levine L, Waalkes TP, Stolbach L. Serum levels of N2, N2-dimethylguanosine and pseudouridine as determined by radioimmunoassay for patients with malignancy. J Natl Cancer Inst. 1975 Feb; 54(2):341-3.
|
|
|
|
|
38.
|
Inglis NR, Kirley S, Stolbach LL, Fishman WH. Phenotypes of the Regan isoenzyme and identity between the placental D-variant and the Nagao isoenzyme. Cancer Res. 1973 Jul; 33(7):1657-61.
|
|
|
|
|
39.
|
Byrne M, Heppner G, Stolbach L, Cummings F, McDonough E, Calabresi P. Tumor immunity in melanoma patients as assessed by colony inhibition and microcytotoxicity methods: a preliminary report. Natl Cancer Inst Monogr. 1973 Jun; 37:3-8.
|
|
|
|
|
40.
|
Constantopoulos A, Najjar VA, Wish JB, Necheles TH, Stolbach LL. Defective phagocytosis due to tuftsin deficiency in splenectomized subjects. Am J Dis Child. 1973 May; 125(5):663-5.
|
|
|
|
|
41.
|
Heppner GH, Stolbach L, Byrne M, Cummings FJ, McDonough E, Calabresi P. Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma. Int J Cancer. 1973 Mar 15; 11(2):245-60.
|
|
|
|
|
42.
|
Cummings FJ, Heppner GH, Stolbach L, Calabresi P. Demonstration of cell-mediated and blocking immune responses to tumor antigens in cancer patients with the colony-inhibition-in-gel test. Isr J Med Sci. 1973 Mar; 9(3):308-16.
|
|
|
|
|
43.
|
Stolbach L, Skillman J, Goodman R. Increase in serum alkaline phosphatase due to Regan isoenzyme in a patient with localized jejunal lymphoma. Arch Surg. 1972 Sep; 105(3):491-3.
|
|
|
|
|
44.
|
Stolbach LL, Krant MJ, Fishman WH. Intestinal alkaline phosphatase in chylous effusion: role of ABO blood group and secretor status. Enzymologia. 1972 Jun 30; 42(6):431-8.
|
|
|
|
|
45.
|
Inglis NR, Fishman L, Stolbach LL, Warshaw JB, Fishman WH. A comparison of chyle isoenzymes of alkaline phosphatase in chyle and hypophosphatasemic sera. Clin Chim Acta. 1972 Apr; 38(1):67-73.
|
|
|
|
|
46.
|
Cantor F, Green S, Stolbach LL, Fishman WH. Quality control of an automated differential isoenzyme assay of alkaline phosphatase, with use of L-phenylalanine inhibition. Clin Chem. 1972 Apr; 18(4):391-2.
|
|
|
|
|
47.
|
Warshaw JB, Littlefield JW, Fishman WH, Inglis NR, Stolbach LL. Serum alkaline phosphatase in hypophosphatasia. J Clin Invest. 1971 Oct; 50(10):2137-42.
|
|
|
|
|
48.
|
Stolbach LL. Clinical application of alkaline phosphatase isoenzyme analysis. Ann N Y Acad Sci. 1969 Oct 14; 166(2):760-74.
|
|
|
|
|
49.
|
Stolbach LL, Krant MJ, Fishman WH. Ectopic production of an alkaline phosphatase isoenzyme in patients with cancer. N Engl J Med. 1969 Oct 2; 281(14):757-62.
|
|
|
|
|
50.
|
Stolbach LL, Krant MJ, Mitchell ML. The effect of 6-medroxyprogesterone acetate (Provera) on [131-I]tri-iodothyronine resin sponge uptake. J Endocrinol. 1969 Feb; 43(2):309-10.
|
|
|
|
|
51.
|
Fishman WH, Inglis NR, Green S, Anstiss CL, Gosh NK, Reif AE, Rustigian R, Krant MJ, Stolbach LL. Immunology and biochemistry of Regan isoenzyme of alkaline phosphatase in human cancer. Nature. 1968 Aug 17; 219(5155):697-9.
|
|
|
|
|
52.
|
Fishman WH, Inglis NI, Stolbach LL, Krant MJ. A serum alkaline phosphatase isoenzyme of human neoplastic cell origin. Cancer Res. 1968 Jan; 28(1):150-4.
|
|
|
|
|
53.
|
Stolbach LL, Krant MJ, Inglis NI, Fishman WH. Correlation of serum L-phenylalanine-sensitive alkaline phosphatase, derived from intestine, with the ABO blood group of cirrhotics. Gastroenterology. 1967 May; 52(5):819-27.
|
|
|
|
|
54.
|
STOLBACH L, EPPES RB, STOCKDALE F, MEHLER R, WIELAND RG. HYPOPITUITARISM PRESENTING AS HYPOADRENOTROPISM. A DISCUSSION OF TWO INTERESTING CASES. Ohio State Med J. 1965 Aug; 61:721-4.
|
|
|
|
|
55.
|
ROSS GT, STOLBACH LL, HERTZ R. Actinomycin D in the treatment of methotrexate-resistant trophoblastic disease in women. Cancer Res. 1962 Sep; 22:1015-7.
|
|
|
|
|
56.
|
STOLBACH LL, NISSELBAUM JS, FISHMAN WH. A simplified technic for measuring serum acid phosphatase of prostatic origin (Fishman-Lerner method). Am J Clin Pathol. 1958 Apr; 29(4):379-84.
|
|
|
|
|
57.
|
STOLBACH LL, NISSELBAUM JS, FISHMAN WH. A simplified technic for measuring serum acid phosphatase of prostatic origin (Fishman-Lerner method). Tech Bull Regist Med Technol. 1958 Mar; 28(3):43-8.
|
|
|
|
